These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2082484)

  • 21. Prevention of aortocoronary vein bypass graft occlusion: which antithrombotic treatment and for how long?
    Pfisterer M; Burkart F; Jockers G; Meyer B; Regenass S; Burckhardt D; Schmitt HE; Müller-Brand J; Skarvan K; Stulz P
    Thromb Res Suppl; 1990; 12():11-21. PubMed ID: 2082483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Dipyridamole and low-dose aspirin in patients with aortocoronary bypass--comparison with anticoagulants].
    Loeliger EA
    Schweiz Med Wochenschr; 1988 Mar; 118(12):447-9. PubMed ID: 3259724
    [No Abstract]   [Full Text] [Related]  

  • 23. Randomised placebo controlled trial of aspirin and dipyridamole in the prevention of coronary vein graft occlusion.
    Brooks N; Wright J; Sturridge M; Pepper J; Magee P; Walesby R; Layton C; Honey M; Balcon R
    Br Heart J; 1985 Feb; 53(2):201-7. PubMed ID: 3881108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improvement in early saphenous vein graft patency after coronary artery bypass surgery with antiplatelet therapy: results of a Veterans Administration Cooperative Study.
    Goldman S; Copeland J; Moritz T; Henderson W; Zadina K; Ovitt T; Doherty J; Read R; Chesler E; Sako Y
    Circulation; 1988 Jun; 77(6):1324-32. PubMed ID: 3286040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of various antithrombotic regimens (aspirin, aspirin plus dipyridamole, anticoagulants) on the functional status of patients and grafts one year after coronary artery bypass grafting.
    Mulder BJ; van der Doef RM; van der Wall EE; Tijssen JG; Piek JJ; van der Meer J; Dunning AJ
    Eur Heart J; 1994 Aug; 15(8):1129-34. PubMed ID: 7988607
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of dipyridamole in addition to low dose aspirin in the prevention of occlusion of coronary artery bypass grafts.
    Agnew TM; French JK; Neutze JM; Whitlock RM; Brandt PW; Kerr AR; Webber BJ; Rutherford JD
    Aust N Z J Med; 1992 Dec; 22(6):665-70. PubMed ID: 1489290
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Internal mammary artery and saphenous vein graft patency. Effects of aspirin.
    Goldman S; Copeland J; Moritz T; Henderson W; Zadina K; Ovitt T; Kern KB; Sethi G; Sharma GV; Khuri S
    Circulation; 1990 Nov; 82(5 Suppl):IV237-42. PubMed ID: 2225410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A platelet-inhibitor-drug trial in coronary-artery bypass operations: benefit of perioperative dipyridamole and aspirin therapy on early postoperative vein-graft patency.
    Chesebro JH; Clements IP; Fuster V; Elveback LR; Smith HC; Bardsley WT; Frye RL; Holmes DR; Vlietstra RE; Pluth JR; Wallace RB; Puga FJ; Orszulak TA; Piehler JM; Schaff HV; Danielson GK
    N Engl J Med; 1982 Jul; 307(2):73-8. PubMed ID: 7045659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiplatelet drugs in femoropopliteal vein bypasses: a multicenter trial.
    McCollum C; Alexander C; Kenchington G; Franks PJ; Greenhalgh R
    J Vasc Surg; 1991 Jan; 13(1):150-61; discussion 161-2. PubMed ID: 1987387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts.
    Stein PD; Dalen JE; Goldman S; Théroux P
    Chest; 1998 Nov; 114(5 Suppl):658S-665S. PubMed ID: 9822069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors influencing 1-year patency of coronary artery saphenous vein grafts. Studio Indobufene nel Bypass Aortocoronarico (SINBA).
    Cataldo G; Braga M; Pirotta N; Lavezzari M; Rovelli F; Marubini E
    Circulation; 1993 Nov; 88(5 Pt 2):II93-8. PubMed ID: 8222202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of platelets and platelet inhibitors in aortocoronary artery vein-graft disease.
    Fuster V; Chesebro JH
    Circulation; 1986 Feb; 73(2):227-32. PubMed ID: 3510762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acetylsalicylic acid and dipyridamole improve the early patency of aorta-coronary bypass grafts. A double-blind, placebo-controlled, randomized trial.
    Rajah SM; Salter MC; Donaldson DR; Subba Rao R; Boyle RM; Partridge JB; Watson DA
    J Thorac Cardiovasc Surg; 1985 Sep; 90(3):373-7. PubMed ID: 3897722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts.
    Stein PD; Dalen JE; Goldman S; Schwartz L; Théroux P; Turpie AG
    Chest; 1995 Oct; 108(4 Suppl):424S-430S. PubMed ID: 7555193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of Ticagrelor Plus Aspirin, Ticagrelor Alone, or Aspirin Alone on Saphenous Vein Graft Patency 1 Year After Coronary Artery Bypass Grafting: A Randomized Clinical Trial.
    Zhao Q; Zhu Y; Xu Z; Cheng Z; Mei J; Chen X; Wang X
    JAMA; 2018 Apr; 319(16):1677-1686. PubMed ID: 29710164
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Meta-analysis of effect of single versus dual antiplatelet therapy on early patency of bypass conduits after coronary artery bypass grafting.
    Nocerino AG; Achenbach S; Taylor AJ
    Am J Cardiol; 2013 Nov; 112(10):1576-9. PubMed ID: 24035160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved graft patency in patients treated with platelet-inhibiting therapy after coronary bypass surgery.
    Brown BG; Cukingnan RA; DeRouen T; Goede LV; Wong M; Fee HJ; Roth JA; Carey JS
    Circulation; 1985 Jul; 72(1):138-46. PubMed ID: 3874009
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Permeability of aortocoronary bypass after 6 months. A multicenter French study].
    Ollivier JP
    Arch Mal Coeur Vaiss; 1991 Apr; 84(4):537-42. PubMed ID: 2064515
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of ibustrin on early aortocoronary bypass patency.
    Pirk J; Rohn V; Peregrin J
    Cor Vasa; 1990; 32(3):258-62. PubMed ID: 2209029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of antiplatelet agents in the prevention of aorto-coronary bypass occlusion.
    Verstraete M; Brown BG; Chesebro JH; Ekeström S; Harker LA; Henderson AH; Jewitt DE; Oliver MF; Sleight P
    Eur Heart J; 1986 Jan; 7(1):4-13. PubMed ID: 3514223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.